Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zalcberg

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Expert Opinion on Investigational Drugs|July 12, 2005
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancerKenneth Khamly, Michael Jefford, Michael Michael, et al.
ANZ Journal of Surgery|November 8, 2024
Filling the information void for the benefit of patients: why AANZ need a population-based clinical quality registry for pancreatic cancer surgeryElizabeth Lockie, John Zalcberg, Anita Skandarajah, et al.
Journal of Geriatric Oncology|September 16, 2020
The acceleration of ageing in older patients with cancerJaidyn Muhandiramge, Suzanne Orchard, Andrew Haydon, et al.
Australian Health Review : a Publication of the Australian Hospital Association|February 9, 2018
Towards a strategy for clinical quality registries in AustraliaSusannah Ahern, Sue Evans, Ingrid Hopper, et al.
Expert Opinion on Investigational Drugs|January 26, 2006
Recent developments in the systemic therapy of advanced gastroesophageal malignanciesKenneth Khamly, Michael Jefford, Michael Michael, et al.
Therapeutic Innovation & Regulatory Science|April 29, 2024
Implementing Decentralized Clinical Trials in Australia through Teletrials: Where to From Here?Tanya Symons, Anne Woollett, John Zalcberg, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 23, 2003
Applications of positron emission tomography in the development of molecular targeted cancer therapeuticsBenjamin Solomon, Grant McArthur, Carleen Cullinane, et al.
Expert Opinion on Pharmacotherapy|February 24, 2022
Chemotherapy in resectable or potentially resectable colon cancer with liver metastasesZarka Samoon, Sayeda Kamrun Naher, Katrin M Sjoquist, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2024
Exploring patient reported quality of life in lung cancer patients: A qualitative study of patient-reported outcome measuresElena Jensen-Marini, Darshini Ayton, John Zalcberg, et al.
ANZ Journal of Surgery|December 26, 2024
Re: Simulating the healthcare workforce impact and capacity for pancreatic cancer care in Victoria: a model-based analysisElizabeth B Lockie, John Zalcberg, Anita Skandarajah, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|July 12, 2005
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancerKenneth Khamly, Michael Jefford, Michael Michael, et al.
ANZ Journal of Surgery|November 8, 2024
Filling the information void for the benefit of patients: why AANZ need a population-based clinical quality registry for pancreatic cancer surgeryElizabeth Lockie, John Zalcberg, Anita Skandarajah, et al.
Journal of Geriatric Oncology|September 16, 2020
The acceleration of ageing in older patients with cancerJaidyn Muhandiramge, Suzanne Orchard, Andrew Haydon, et al.
Australian Health Review : a Publication of the Australian Hospital Association|February 9, 2018
Towards a strategy for clinical quality registries in AustraliaSusannah Ahern, Sue Evans, Ingrid Hopper, et al.
Expert Opinion on Investigational Drugs|January 26, 2006
Recent developments in the systemic therapy of advanced gastroesophageal malignanciesKenneth Khamly, Michael Jefford, Michael Michael, et al.
Therapeutic Innovation & Regulatory Science|April 29, 2024
Implementing Decentralized Clinical Trials in Australia through Teletrials: Where to From Here?Tanya Symons, Anne Woollett, John Zalcberg, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 23, 2003
Applications of positron emission tomography in the development of molecular targeted cancer therapeuticsBenjamin Solomon, Grant McArthur, Carleen Cullinane, et al.
Expert Opinion on Pharmacotherapy|February 24, 2022
Chemotherapy in resectable or potentially resectable colon cancer with liver metastasesZarka Samoon, Sayeda Kamrun Naher, Katrin M Sjoquist, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2024
Exploring patient reported quality of life in lung cancer patients: A qualitative study of patient-reported outcome measuresElena Jensen-Marini, Darshini Ayton, John Zalcberg, et al.
ANZ Journal of Surgery|December 26, 2024
Re: Simulating the healthcare workforce impact and capacity for pancreatic cancer care in Victoria: a model-based analysisElizabeth B Lockie, John Zalcberg, Anita Skandarajah, et al.
Pageof 15